TUBERCULOSIS RV2386C PROTEIN, COMPOSITIONS AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140086948A1
SERIAL NO

13929232

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to a polypeptide which comprises: (i) an Rv2386c protein sequence; (ii) a variant of an Rv2386c protein sequence; of (iii) an immunogenic fragment of an Rv2386c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXOSMITHKLINE BIOLOGICALS S A1330 RIXENSART

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BROWN, JAMES COLLEGEVILLE, US 205 2256
METTENS, PASCAL RIXENSART, BE 23 66
MURPHY, DENNIS COLLEGEVILLE, US 43 268

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation